T he field of communication disorders encompasses a wide range of clinical disciplines that draw people from diverse educational backgrounds such as education, linguistics, psychology, engineering, physics, and biology. The intellectual diversity in this field is advantageous because it provides a tremendous degree of flexibility when designing more effective treatments for the clients whom we aim to serve. One drawback in such an expansive field is that it may be difficult for experts in a given specialty to interpret new findings in a closely related field.
The purpose of this article is to present a broad overview of biotechnological applications for the treatment of hearing loss. The goal is to provide basic information to both clinicians and researchers in the fields of communication disorders that will assist in the interpretation of the current work in stem cell and gene therapy. This information is important to researchers because it may help in the assessment of the current literature and, perhaps, inspire future collaborations, and it is important to clinicians because it will help answer queries from clients who are seeking information about novel treatments for hearing loss.
Significance of Biological Approaches for the Treatment of Hearing Loss
As many as three of every 1,000 individuals in the United States are born deaf or exhibit a hearing loss (National Institute on Deafness and Other Communication Disorders [NIDCD], 2008) ; however, as a person advances in age, their chance of developing a hearing loss increases. It is estimated that 17% of adults in the United States exhibit some degree of hearing loss (NIDCD, 2003) . Thirty percent of people over the age of 65 years exhibit a hearing loss, and this percentage increases to 47% of people 75 years of age and older (NIDCD, 2008) . Regardless of the etiology, the death or dysfunction of mechanosensory hair cells located within the organ of Corti of the cochlea is the primary cause of sensorineural deafness (see Figure 1 ). For example, overexposure to noise (Wang, Hirose, & Liberman, 2002) or to aminoglycoside antibiotics (Forge & Schacht, 2000) results in hair cell loss and subsequent sensorineural hearing loss (SNHL). In some instances, the supporting cells, which act to maintain the ionic balance within the organ of Corti and provide structural support for hair cells (reviewed in Raphael & Altschuler, 2003) , remain intact after damage. In other instances, such as a focal lesion caused by exposure to narrow-band noise, specific regions of the organ of Corti become ablated, and the remaining cells form a flat epithelium that spans the basilar membrane . Therefore, SNHL can be viewed as a biological disorder caused by death or dysfunction of particular cell types within the cochlea. The current treatments for SNHL are based on electronic technologies such as amplification of the speech signal using hearing aids and electrical stimulation of the surviving spiral ganglion neurons using cochlear implants.
Many cases of postlingual SNHL, such as presbycusis, are treated using amplification provided by hearing aids. Although hearing aids do not restore normal hearing, they do provide significant communication benefits for those who exhibit mild-to-moderate hearing loss, and they exhibit a good ability to discriminate speech stimuli (Vuorialho, Karinen, & Sorri, 2006) . However, there is a significant population with severe-to-profound SNHL who receive minimal communication benefits from hearing aids (Cohen, Labadie, Dietrich, & Haynes, 2004) .
Severe-to-profound SNHL is commonly treated using cochlear implants, which directly stimulate the surviving auditory nerve fibers (Clark, 1975) . In terms of speech recognition in quiet environments, it has been proven that cochlear implants are more effective than hearing aids for those who exhibit severe-to-profound SNHL (Cohen et al., 2004; Parving, 2003) . In the absence of any other disabilities, a significant number of children who have received cochlear implants can be expected to acquire speech and language at a rate similar to that of their hearing peers and can attain satisfactory educational and The cochlea is composed of many cell types, including bone (purple), ligament, sensory epithelia, and nerve that enables communication between the sensory epithelia and the brain. Panel B: Close-up of the sensory epithelium (boxed region in Panel A) illustrates the organ of Corti, which consists of inner and outer hair cells and their corresponding supporting cells. Hair cells are responsible for transducing the mechanical motion of the basilar membrane into neural impulses that can be interpreted as sound by the brain. The supporting cells act to provide structural and nutritional support for hair cells and, possibly, act as hair cell progenitors as well. Panel C: Ototoxic damage, such as exposure to noise or aminoglycoside antibiotics, results in hair cell loss and subsequent hearing loss. In some instances, the supporting cells remain intact after damage and may act as a target for gene therapy. Panel D: It is also possible for ototoxic damage to completely ablate the organ of Corti. In such an instance, the remaining cells form a flat epithelium that spans the basilar membrane.
academic performance (Uziel et al., 2007) . Furthermore, longitudinal studies suggest that the long-term benefits in oral communication continue long after implantation (Beadle et al., 2005) .
As encouraging as the results of cochlear implants appear to be, their use does not restore normal hearing. For instance, some social activities diminish the effectiveness of cochlear implants (e.g., eating in crowded restaurants that contain a high degree of background conversational noise) or preclude use of the device (e.g., swimming, participating in contact sports). Although it appears that, in the best cases, cochlear implant recipients can be expected to learn speech and language at a rate similar to that of their hearing pears (Geers, Nicholas, & Sedey, 2003) , there is a wide variation on performance even when controlling for age of implantation, time between deafness and implantation, insertion depth, implant device, and speech processor settings (reviewed in B. S. Wilson & Dorman, 2008a , 2008b B. S. Wilson, Lawson, Muller, Tyler, & Kiefer, 2003) . Along with the high degree of variability in performance, cochlear implant users generally also perform poorly in the presence of background noise-a difficulty that is exacerbated when the competing noise consists of speech stimuli (Donaldson et al., 2009; Plyler, Bahng, & von Hapsburg, 2008; Turner, Reiss, & Gantz, 2008) . Cochlear implant recipients also exhibit a relatively poor ability to localize sound, an effect that is noted particularly in patients with unilateral implants (B. S. Wilson & Dorman, 2008b) . Although research has shown that bilateral implantation or bimodal stimulation using a contralateral hearing aid improves the ability to detect speech in noise and perhaps to localize sound, there is large subject variability for these tasks as well (reviewed in Das & Buchman, 2005; Johnston, Durieux-Smith, Angus, O'Connor, & Fitzpatrick, 2009; Olson & Shinn, 2008) . Finally, cochlear implant recipients exhibit poor pitch perception, which interferes with perception of music even with optimal programming aimed to restore music perception (Gfeller et al., 2002) . Similarly, cochlear implant recipients exhibit poor representation of tonal languages, such as Punjabi of India and Chinese languages such as Mandarin, Cantonese, and Taiwanese (Fu, Hsu, & Horng, 2004; Fu, Zeng, Shannon, & Soli, 1998; Luo & Fu, 2004; Peng, Tomblin, Cheung, Lin, & Wang, 2004) . Therefore, a significant population of individuals who are deaf who would communicate using tonal languages are underserved with current implant technologies.
Although implant technology has advanced significantly since the development of the first devices, some evidence shows that the benefits derived from the current implant has plateaued (reviewed in Clark, 2008 Clark, , 2009 B. S. Wilson & Dorman, 2008b) . Recent attempts to address the deficiencies of current implant technology have focused on improved speech-processing capabilities, such as amplitude modulation of the speech signal (Luo & Fu, 2004) , bimodal stimulation using a hearing aid simultaneously (Blamey, Dooley, James, & Parisi, 2000; Mok, Grayden, Dowell, & Lawrence, 2006; Waltzman, Cohen, & Shapiro, 1992) , and integration of implant technology with biological approaches aimed to preserve the endogenous auditory neurons (Chikar et al., 2008; Rejali et al., 2007; Yagi et al., 2000) . These areas of research are promising, but at this time, some are still at the basic level.
In contrast to the use of amplification or electrical stimulation to treat SNHL, a growing body of work is focused on using biotechnology for this aim (reviewed in Atar & Avraham, 2005; Batts & Raphael, 2007; Beisel, Hansen, Soukup, & Fritzsch, 2008; Brigande & Heller, 2009; Coleman, de Silva, & Shepherd, 2007; Cotanche, 2008; Groves, 2010; Holley, 2002; Parker & Cotanche, 2004; Patel, Mhatre, & Lalwani, 2004; Raphael, Kim, Osumi, & Izumikawa, 2007) . Biological approaches, such as stem cell and gene therapy, attempt to restore hearing by repairing the damaged structures of the auditory system. In particular, regenerating cochlear hair cells has been the main focus of these biological approaches. Although the initial research on cochlear implants started in the 1950s (Djourno, Eyries, & Vallancien, 1957) , exploration of biological approaches for the treatment of SNHL did not start until after the discovery that birds possessed the capacity to repair their auditory organs after damage (Corwin & Cotanche, 1988; Ryals & Rubel, 1988) . When compared with hearing aids and cochlear implants, biological treatments are in their infancy and will not be ready for human trials for many years. However, significant progress has been made in the identification of the mechanisms responsible for hair cell regeneration, and the use of biotechnological approaches have led to new methods of regenerating hair cells. The methodologies of the biological approaches are based on the fields of cellular and molecular biology, developmental biology, and tissue regeneration. Therefore, a review of the current state of biotechnology as it is applied to the treatment of SNHL-particularly, stem cell therapy and gene therapy-is provided here.
Cellular and Molecular Biology of Hearing Research
The current research on hair cell regeneration is based primarily on cellular and molecular biology. Therefore, an understanding of the basic principles in these fields assists the reader in comprehending the methodologies and interpreting the research involved in hair cell regeneration. Additionally, this overview provides the reader with an introduction to the common experimental tools used to examine hair cell regeneration.
The cell is the basic unit of study for cellular biologists (see Figure 2) . The outer plasma membrane is hydrophobic and acts as a semipermeable barrier between the cytoplasm within the cell and the extracellular fluid (for reference, please see Chapter 1 of Alberts, Johnson, Lewis, & Raff, 2007) . The plasma membrane contains many different types of proteins, some of which can act as either receptors for extracellular signals (also called ligands) or as channels through which ions can enter or exit. One example of a ligand-receptor interaction is the neurotransmitter of the nervous system, whereby a neurotransmitter such as glutamate is secreted from nearby neurons and binds to a glutamate receptor on the cellular membrane (for reference, please see Chapter 10 of Kandel, Schwartz, & Jessell, 2000) .
When a ligand binds to its receptor, a biochemical signaling cascade may be initiated within the cell, depending on the type of receptor that is activated (for reference, please see Chapter 10 of Kandel et al., 2000) . In this process, called signal transduction, an extracellular ligand may cause many different biochemical reactions to occur within the cytoplasm. For example, ligand binding may cause molecule A to be activated, which in turn activates molecule B, and so on. In some cases, the signaling cascade influences other biochemical reactions within the plasma membrane or the cytoplasm. In other cases, such as in the activation of proteins called transcription factors, activation will cause the molecule to be transported into the nucleus of a cell, where it may influence the expression of certain genes (Wilhelm, Johnson, Haselkorn, & Geiduschek, 1972) . In some biotechnological approaches to the treatment of SNHL, researchers exploit the endogenous signaling pathways involved in hair cell regeneration in order to study their therapeutic effects on hearing loss. For example, the addition of retinoic acid (Kelley, Xu, Wagner, Warchol, & Corwin, 1993) or DAPT (Woods, Montcouquiol, & Kelley, 2004) to the embryonic organ of Corti of mice stimulates signaling pathways that lead to production of extra (supernumerary) hair cells.
Typically, the signaling pathways involved in hair cell regeneration include the activation of pro-hair cell genes; this activation leads to hair cell differentiation. A gene is a specific region of deoxyribonucleic acid ( DNA) that codes for the production of a specific protein (for reference, please see Chapter 6 of Alberts et al., 2007) . Genes are typically quiescent and are not expressed until transcription factors bind to a region of DNA called a promoter (see Figure 3) . Promoters, therefore, are small regions of DNA that are responsible for activating a gene-of-interest. Each gene has a specific promoter, and several transcription factors may be required to bind to the promoter before a gene is expressed. Once the appropriate signaling molecules are bound to its promoter, the gene may be copied into a ribonucleic acid (RNA) molecule in a process called transcription (Kidson & Kirby, 1964; Somerville & Yanofsky, 1964) . Whereas the DNA molecule is restricted to the nucleus, RNA molecules may be shuttled out of the nucleus into the cytoplasm, where they may be copied into a protein in a process called translation (for reference, please see Chapter 6 of Alberts et al., 2007) . Proteins play crucial roles in normal cell physiology. For example, proteins are responsible for initiating cell division and cell death, comprising receptors, enabling the structural morphology of a cell, catalyzing cytoplasmic biochemical reactions, acting as signals in the signaling cascade, and acting as transcription factors that bind to the promoter region of DNA and activate gene transcription. Proteins are also used as molecular markers for different types of cells. For example, hair cells are the only cell types in the cochlea that express the myosin 7a protein (Gillespie, 1995) . Therefore, expression of the myosin 7a gene, RNA, or protein can be used as a molecular marker for cochlear hair cells.
The identification of pro-hair cell genes and the regulation of their expression is a growing area of research in hair cell regeneration (see Developmental Biology of the Auditory System section below). Methods developed in the field of molecular genetics are used to observe gene expression in the live animal (in vivo) or in live tissue cultured in an incubator (in vitro). Individual genes, RNA, and many proteins are too small to be visualized with microscopes. However, the use of transgenic technology has led to new uses of DNA as a tool to study cell biology in vitro. Transgenics refers to the addition of a gene from one animal into the DNA of another (Gordon & Ruddle, 1982) . A common method to measure gene expression is to insert an easily detectable geneknown as a reporter gene-into the host DNA just after the gene-of-interest. For example, the jelly fish Aequorea victoria expresses a gene that codes for a protein that emits a green fluorescent protein (GFP) in the presence of blue light (Shimomura, Johnson, & Saiga, 1962) . GFP is widely used as a visible marker that can be inserted into target genes in order to help determine their modes of expression. If the GFP gene is inserted in the proper manner into the DNA of a host, the GFP gene is . Each gene has a specific promoter, and several factors may be required to bind to the promoter before transcription of the gene into RNA may begin (yellow arrow). Panel C: A common method to measure gene expression is to insert an easily detectable gene, such as the gene for green fluorescent protein (GFP), into the DNA just after the gene-of-interest. In this model, the GFP gene will be transcribed and then translated into protein at the same time as the gene-of-interest. The GFP protein is easily detected using a fluorescent microscope. Panel D:
In some cases, such as when the control of gene expression is to be measured, the molecular tag is inserted into the DNA after the promoter rather than after the gene-of-interest. Panel E. In a gene knock-out organism, the gene-of-interest has been deleted or otherwise mutated to render it dysfunctional. Sometimes, the gene-of-interest is deleted and is replaced by a molecular marker such as GFP (D).
transcribed along with the gene-of-interest (Chalfie, Tu, Euskirchen, Ward, & Prasher, 1994; Prasher, McCann, & Cormier, 1985 ; see Figure 3C ). The resulting translated protein will exhibit a green fluorescence that is easily detectable when viewed in a fluorescence microscope. Auditory researchers have applied similar transgenics to their research as well. For example, transgenic mice have been bred that exhibit fluorescent labeling of the myosin 7a protein which allows for the analysis of hair cells in vitro (Boeda, Weil, & Petit, 2001) . Similarly, strains of transgenic mice have been engineered to exhibit cell-specific GFP labeling of supporting cells (Rio, Dikkes, Liberman, & Corfas, 2002) and neurons (Feng et al., 2000) .
Another way to measure gene expression is to perform assays to detect specific RNA molecules that are transcribed from a gene-of-interest. A procedure called in situ hybridization ( ISH) is commonly used to detect or localize RNA expression in tissue during development (for reference, please see Chapter 8 of Alberts et al., 2007) . In this procedure, animal tissue is fixed, and a probe that will bind to an RNA molecule-of-interest is added to the tissue. The RNA probe typically contains a molecular tag such as a fluorescent marker in order to determine which cell types express the RNA molecule. Another method commonly used to detect RNA expression is called reverse transcriptase polymerase-chain reaction ( for reference, please see Chapter 8 of Alberts et al., 2007) . In this procedure, all of the intracellular RNA is isolated from the tissue and then is converted back into DNA fragments (also known as complimentary DNA [cDNA]) using a technique called reverse transcription. The resulting pool of cDNA represents all of the genes being expressed at a particular time. To determine the expression of a specific gene within this cDNA library, researchers use probes to generate copies of a gene-ofinterest in a technique called a polymerase chain reaction. These genes are then identified by loading them in an agarose gel and applying an electrical current that separates the genes by their size.
A procedure called immunohistochemistry (or immunofluorescence) is commonly used to detect the presence of proteins such as myosin 7a that may act as cell-specific markers (for reference, please see Chapter 8 of Alberts et al., 2007) . In this procedure, an antibody that binds specifically to the myosin 7a protein is used as a molecular tag for the native myosin 7a proteins present in the hair cells. Next, a fluorescent label is added to the antibody so that the antibody/myosin 7a protein complex can then be viewed using a fluorescent microscope. Immunohistochemestry (immunolabeling) is used routinely to label specific cells in the cochlea such as spiral ganglion neurons (e.g., bIII-tubulin [Molea, Stone, & Rubel, 1999] ), neurofilament (Anniko, Thornell, Gustavsson, & Virtanen, 1986) , supporting cells (e.g., p27kip1 [Chen & Segil, 1999] , prox1 [Bermingham-McDonogh et al., 2006] ), or hair cells (e.g., myosin 6 [Hasson et al., 1997] and myosin 7a [Gillespie, 1995] ).
The biotechnological approaches to the treatment of SNHL use a combination of these approaches to study the cellular and molecular mechanisms required for hair cell regeneration. Current research has become more focused on the identifying the essential signal transduction pathways, gene regulation, and gene expression required for normal hair cell development and hair cell regeneration after damage. Next, a review of hair cell development and regeneration is presented. Current cellular and molecular biological techniques used in these fields are highlighted.
Developmental Biology of the Auditory System
An understanding of the mechanisms that control the normal development of the cochlea is crucial to the goal of repairing the damaged cochlea. There is a growing body of research on the developmental biology of the inner ear that describes the normal signaling required for hair cell genesis during embryonic development (reviewed in Alsina, Giraldez, & Pujades, 2009; Kelly & Chen, 2009; Morsli, Choo, Ryan, Johnson, & Wu, 1998; Schwander, Kachar, & Muller, 2010) . Hypothetically, the repair processes involved in hair cell regeneration could be based on similar mechanisms.
Most of the developmental studies of the cochlea use the mouse for the animal model. The mouse is an optimal animal model because mice are mammals with cochlear morphology similar to that of humans (albeit on a smaller scale); they breed relatively quickly, which facilitates the pace of research; and the sequence of their genome is known and can therefore be modified (see gene knock-out discussion below). In the mouse, normal cochlear development begins approximately 8.5 days after fertilization (embryonic day [E] 8.5), when cells on the lateral wall of the fetus thicken to form the otic placode (Hartman, Reh, & Bermingham-McDonogh, 2010 ; see Figure 4 ). Next, these cells begin to divide and proliferate, invaginate from the lateral wall, and then pinch off to form the otic vesicle (otocyst) by E9 (Anniko & Wikstrom, 1984) . Between E12 and E16, a portion of the otocyst called the prosensory domain, which later develops into the organ of Corti, begins to express a gene called p27 kip1 , which inhibits these cells from dividing (Chen & Segil, 1999) . Once the cells within the prosensory domain stop dividing, the maturation of these cells begins. Hair cell development begins within the prosensory domain at E13 (reviewed in Barald & Kelley, 2004; Driver & Kelley, 2009) , and the developing hair cells signal their surrounding cells to differentiate into supporting cells ( likely through lateral inhibition via the Notch signaling pathway; Zine, Van De Water, & de Ribaupierre, 2000) approximately 1 day later (Anniko, 1983) . Individual pillar cells are the first supporting cells to differentiate (Thelen, Breuskin, Malgrange, & Thiry, 2009 ) and appear in the mouse as early as E15 (Anniko, 1983) . By E18, most of the supporting cell types are present in the lateral sensory epithelium, including Hensen's cells and Dieters' cells (Bermingham-McDonogh et al., 2006) . However, the supporting cells of the inner hair cell region will not develop until after birth in the mouse (Pujol & Hilding, 1973) . Instead, the space between the spiral limbus and the row of inner hair cells consists of columnar epithelial cells collectively called Kölliker's organ (also known as the greater epithelial ridge [GER]; Hinojosa, 1977; Kikuchi & Hilding, 1965) . At birth, all of the cell types lateral to the inner hair cells are present; however, development of the inner sulcus, tunnel of Corti, tectorial membrane, and hair cell innervation is incomplete until postnatal day 16 ( P16; Pujol & Hilding, 1973; Tritsch, Yi, Gale, Glowatzki, & Bergles, 2007) , which is approximately the time that the organ of Corti begins to produce adultlike responses in mice (Alford & Ruben, 1963) .
Early research on the development of the cochlea was performed by anatomists who described the morphological changes that occur in the fetus and that lead to the development of the inner ear (Friedmann, [1998] , "Development of the mouse inner ear and origin of its sensory organs," The Journal of Neuroscience, 18, . Panel E: Cross-section through the E12 otocyst (left dashed line in D) highlights a group of cells that immunolabel for the Jagged-1 protein (Jag1; green), which labels the prosensory domain in the developing cochlea that will develop into the organ of Corti. Panel F: Cross-section through the postnatal day 1 (P1) organ of Corti (dashed line on the right side of Panel D) shows that most of the adult cells are present at birth, including hair cells that immunolabel for the myosin 7a protein (green). However, the tunnel of Corti has not developed, and Kölliker's organ (k) remains in place of the inner sulcus. Panel G: The prosensory domain, identified by jag1 and sox2 expression, begins to express p27kip1 between E12 and E16, which initiates maturation of the sensory epithelium (see Panel H). Panel I: Hair cell development begins within the prosensory domain at E13, when hair cells express atoh1 and signal their surrounding cells to differentiate into supporting cells. Panel J: By E18, most of the supporting cell types are present in the sensory epithelium; however, the auditory system is not fully developed until 2 weeks after birth in mice.
1959; F. W. Jones, 1952; Wislocki & Ladman, 1955) . More recently, developmental biologists adopted techniques from cell and molecular biology to identify essential signaling pathways required for cochlear development and hair cell genesis. Developmental biologists use ISH (to localize or detect RNA expression) and immunohistochemistry (to localize or detect protein expression) to identify which genes are expressed during cochlear development. In some cases, particularly during early development, genes are up-regulated for a period of time and are then down-regulated, never to be expressed again (Srinivasan et al., 2007) . In other cases, genes such as myosin 7a are initially quiescent and are then expressed throughout the life span (Sahly, El-Amraoui, Abitbol, Petit, & Dufier, 1997) . These experimental methods are important in the identification of the temporal pattern of gene expression required for hair cell development, but they do not always indicate the function of the gene.
One valuable method used to determine gene function is to engineer an animal (mouse, fruit fly, etc.) in which a particular gene has been deleted or otherwise mutated so as to render it dysfunctional (see Figure 3E ). In this procedure, called knock-out, the animal with the deleted gene is bred, and any morphological changes in the developing animal are analyzed in order to determine the function of the mutated gene (Bernstein & Breitman, 1989; Breitman et al., 1987) . In terms of audition, gene knock-out organisms have helped researchers identify the function of several genes that are important to the development of the inner ear in general and hair cells in particular. Notably, a when a gene called atonal is knocked out in a fruit fly, their hearing organs fail to develop (Akazawa, Ishibashi, Shimizu, Nakanishi, & Kageyama, 1995; . Furthermore, when the atonal knock-out animals were given a new copy of the gene, their auditory organs developed normally (Jarman, Grau, Jan, & Jan, 1993) . Lineage studies-in which transgenic mice express a molecular marker (similar to GFP) to label which cell types express the mammalian form of atonal (atonal homolog 1 [atoh1])-indicate that the cells in the developing mouse cochlea that express atoh1 will differentiate into hair cells (Ben-Arie et al., 2000; Gazit, Krizhanovsky, & Ben-Arie, 2004; Krizhanovsky, Golenser, & Ben-Arie, 2004) . Additionally, knock-out mice that lack the atoh1 gene fail to develop hair cells (Bermingham et al., 1999) . These data indicate that the expression of atoh1 is required for hair cell formation, and studies have suggested the use of atoh1 as a source of gene therapy to treat SNHL (see section titled "Gene Therapy for the Treatment of SNHL").
The study of the cochlear development is a cornerstone of the applied biological approaches to the treatment of hearing loss. As discussed below, knowledge of the molecular signals required for the cellular development of the organ of Corti is crucial for both stem cell and gene therapy used in the treatment of SNHL. Next, a review of tissue regeneration, which is another basis for the applied approaches for hair cell regeneration, is presented.
Tissue Regeneration
The applied approaches to the treatment of SNHL also look to the field of tissue regeneration for models of hair cell regeneration. Many animals exhibit the ability to regenerate body parts after damage. Sea stars (reviewed in Michael, Wei-Chung, Philip, & Marco, 2001) , hydra (reviewed in Hoffmeister-Ullerich, 2007), lizards (reviewed in Alibardi, 2010) , and amphibians such as axolotl salamanders (reviewed in Roy & Gatien, 2008) can spontaneously regenerate entire limbsincluding (in the case of vertebrates) skin, muscle, nerve, and bone-after amputation. In mammals, several adult organs such as the skin (Fukuda et al., 1978) , blood (Nossal & Makela, 1962) , placenta (Pattillo, Gey, Delfs, & Mattingly, 1968) , and intestine (Leblond, Clermont, & Nadler, 1967 ) maintain a limited ability to regenerate. For instance, a scab will form on the epidermal layer of the skin after an abrasion, and eventually, the epidermis will repair itself. The field of tissue regeneration attempts to characterize the morphological, cellular, and molecular mechanisms responsible for tissue repair.
The field of tissue regeneration is also a rich source of information for the biological approaches for the treatment of SNHL. The first evidence that hair cells could be created after normal embryogenesis was published in 1981, when it was found that sharks were able to add new hair cells to their vestibular system as they grew in age (Corwin, 1981) . Although this example is not illustrative of a complete regeneration of the organ, this study was the first to demonstrate that hair cells of some animals could appear after embryonic development. Later in that decade, Douglas Cotanche discovered that bird ears could regenerate their tectorial membrane (Cotanche, 1987b) and cilia of auditory hair cells (Cotanche, 1987a) after noise damage. Additionally, researchers discovered that in birds, the auditory hair cells themselves could regenerate after drug damage (Cruz, Lambert, & Rubel, 1987) or noise damage (Corwin & Cotanche, 1988; Ryals & Rubel, 1988 ; see Figure 5 ). It was later discovered that regenerated hair cells were able to reestablish their neural connections (Ryals & Westbrook, 1994; Stone & Rubel, 2000) , and normal behavioral hearing thresholds could be restored after ototoxic insult (Saunders, Salvi, & Miller, 1995) .
Current theory proposes that there are two mechanisms of hair cell regeneration in birds (reviewed in Stone & Cotanche, 2007 ). An ototoxic stimulus such as sound or drug damage may cause a hair cell to die. Next, the dying hair cell becomes ejected from the sensory epithelium that may trigger hair cell regeneration by the following mechanisms. The first possibility is that cochlear supporting cells will change their morphology to that of a hair cell in a process termed direct transdifferentiation (Roberson, Alosi, & Cotanche, 2004) . The second possibility is that a cochlear supporting cell will undergo cellular division (Stone & Cotanche, 1994) and produce one daughter cell that becomes a regenerated supporting cell and one daughter cell that becomes a regenerated hair cell. Both of these mechanisms are thought to occur in the regenerating chicken cochlea and highlight the critical role of supporting cells in hair cell regeneration.
Further research has demonstrated that hair cell regeneration is not limited to birds but is exhibited by other nonmammalian vertebrates such as fish (Harris et al., 2003; Lombarte, Yan, Popper, Chang, & Platt, 1993) , frogs (Baird, Torres, & Schuff, 1993) , axolotls (J. E. Jones & Corwin, 1993) , and lizards (Avallone et al., 2003) . Notably, the zebrafish has become an attractive animal model for hair cell regeneration for a few reasons. The zebrafish exhibits a rapid rate of hair cell regeneration, with regenerated hair cells appearing 24-48 hr after neomycin treatment (Harris et al., 2003) . Additionally, the hair cells within its lateral line organ are readily visible through use of a microscope from the outside the body; therefore, hair cell regeneration can be observed in vivo using time-lapse videography (Harris et al., 2003) . Finally, the zebrafish is a good model for the Figure 5 . Spontaneous regeneration of auditory hair cells in the chick. Panel 1A: Unlike the mammalian organ of Corti, the auditory sensory epithelium in the chick is covered in many rows of hair cells. Panel 1B: Exposure to loud sound results in significant damage to sensory epithelia including loss of hair cells. Panels 1C, 1E, and 1F: Small ciliated cells spontaneously appear on the surface of the epithelium by 6 days after noise exposure. These cells maintain morphological similarities to developing hair cells. Panel 1D: A significant number of hair cells appear on the epithelia by 10 days after the noise damage. These cells appear morphologically similar to adult hair cells with the exception that the orientations of their cilia are often askew. Image taken from Corwin and Cotanche (1988) reprinted with permission from the American Association for the Advancement of Science (AAAS) and authors. Panel 2: The current model of hair cell regeneration holds that there are two mechanisms of hair cell regeneration in chicks (Stone & Cotanche, 2007) . In each of these models, hair cells are regenerated from supporting cells that survived the ototoxic stimulus (see Panels 2A and 2B). Panel 2C: Initially, supporting cells differentiate into a hair cell in a process called direct transdifferentiation. Panel 2D: Later in the regenerative process, supporting cells enter into the mitotic cycle and undergo cell division. Of the two daughter cells, one will regenerate into a supporting cell, and one will differentiate into a regenerated hair cell. study of gene function because of the relative ease in manipulating their gene expression during development and because they produce many progeny that may be easily screened for genetic mutations that could affect hair cell regeneration (Brignull, Raible, & Stone, 2009) . Considering the disparate species involved, hair cell regeneration is not uncommon because many vertebrates maintain the capacity to repair their peripheral auditory organs after damage. The obvious exception to this finding is that mammals do not possess this capability after normal embryonic development.
The lack of spontaneous hair cell regeneration in the mammalian cochlea does not necessarily mean that mammals lack the capacity for hair cell regeneration. Similar to the vestibular system in sharks, humans exhibit a low level of vestibular hair cell regeneration as they age (Warchol, Lambert, Goldstein, Forge, & Corwin, 1993 ). Additionally, a low level of spontaneous hair cell regeneration is possible in murine embryonic organ of Corti when cultured in vitro (Kelley, Talreja, & Corwin, 1995) , and some signaling molecules involved in fate determination during embryological development such as retinoic acid are able to induce extra hair cell production in murine embryonic organ of Corti explant cultures (Kelley et al., 1993 ) (see Figure 6 ). Finally, it has been shown that cochlear supporting cells in knockout mice that lack the p27 kip1 gene are able to proliferate and become new hair cells (Lowenheim et al., 1999) . However, spontaneous cochlear hair cell regeneration and the ability to induce hair cell proliferation using morphogens (signals involved in the initial stages of organogenesis), mitogens (agents that induce cellular proliferation), growth factors (agents that stimulate cell growth), or inhibition of the cell cycle inhibitor gene p27 kip1 are lost perinatally in mice. Therefore, mammals do possess the capability to regenerate cochlear hair cells, but this ability is lost around the time of birth in mice and earlier in human fetal development. Although researches are continuing their investigations into the mechanisms of hair cell generation in chickens, fish, and other nonmammalian animals, new avenues of research have advanced the field using biotechnological approaches, such as stem cell and gene therapy, to regenerate mammalian hair cells.
Stem Cell Therapy for the Treatment of SNHL
Stem cell therapy, in which exogenous stem cells are used to replace dead or damaged endogenous cell types, is a relatively new technique used to treat many forms of human disease-for example, stem cell therapy is used clinically in the treatment of certain types of leukemia (Kessinger et al., 1989) . Research investigating the possible use of stem cell therapy for the treatment of hearing loss has started within the past decade (Ito, Kojima, & Kawaguchi, 2001; Parker et al., 2003) , and based on promising initial research, this field has expanded and represents a cutting-edge form of therapy. In this section, I first provide a background regarding stem cell biology and then move to the current body of work using stem cell therapy in the treatment of SNHL through use of vivo animal models.
During embryonic development, a sperm fertilizes an egg, and the resulting zygote is the only cell that is totipotent because it maintains the ability to develop into extra-embryonic tissue (such as the umbilical cord) and any cell type within the embryo (for reference, please see Chapter 4 of Gilbert, 2010) . Within a few hours after fertilization, the zygote divides into two daughter cells. These two cells then divide, and so on, until a (mostly) hollow ball of cells-called a blastulais formed. Inside the blastula is a mass of cells called the inner cell mass (or embryonic stem cells).
Embryonic stem cells are pluripotent cells that maintain the ability to develop into any cell type in the developing embryo (see Figure 7A ; for reference, please see Chapter 8 of Gilbert, 2010) . As embryonic stem cells further divide, they become more restricted in the types of cells in which they can differentiate (reviewed in . Near the end of organogenesis, progenitor cells give rise to a small number of cell types within a given organ until a terminal stage of cell division occurs. In the organ of Corti, a common progenitor cell gives rise (Kelley et al., 1993) . The x-axis labels, "-Retinoic acid" and "+Retinoic acid," indicate the absence of and presence of retinoic acid, respectively.
to both hair cells and supporting cells (reviewed in Driver & Kelley, 2009; Kelley, 2006) . As noted above, the development of the hair cell signals surrounding supporting cells to differentiate into supporting cells. Therefore, hair and supporting cells share the same developmental signaling and differentiation patterns until the final stages of terminal differentiation. Evidence of the close relationship between these cell types comes from various studies that describe supporting-cell-to-hair-cell differentiation in the chick (described above) and mammal (White, Doetzlhofer, Lee, Groves, & Segil, 2006) .
Many of the mammalian organs that exhibit regeneration in the adult (i.e., blood, skin, intestine) have been found to contain a niche of stem cells that contribute to regeneration of the organ (Leblond et al., 1967; Shihabuddin, Ray, & Gage, 1999; Weissman, 2000) . Adult stem cells (ASCs) are multipotent cells found in the end-organs of adult tissue. In these organs, when an ASC divides, one of the resulting daughter cells will be a renewed ASC, and the other daughter cell will act as a progenitor cell that will differentiate into cell types of a particular organ (reviewed in Gage, 2000) . In this way, ASCs act to repopulate both themselves and lost or damaged tissue. ASCs, therefore, act in a self-repair mechanism. In 1992, it was discovered that the brain possessed a small population of cells that maintained the functional definition of a stem cell, the ability to self-renew after cell division, and the ability for the daughter cells to differentiate into multiple cell types, such as neurons and astrocytes (Reynolds & Weiss, 1992) . This study was important because it was the first evidence that the brain contained a population of cells that could differentiate into neurons after the critical period of brain development. Further studies indicated that exogenously transplanted neural stem cells could be used to replace damaged nervous tissue such as neurons (E. Y. Snyder, Yoon, Flax, & Macklis, 1997) and glia (Cao, Benton, & Whittemore, 2002) , which highlighted their potential in cell replacement therapy. Additional data have shown that neural stem cells that have been transplanted into the sectioned spinal cord were able to replace damaged nervous tissue and facilitate a recovery of motor function as well (Teng et al., 2002) .
There is speculation that the inner ear may contain a niche of stem cells. In the mouse cochlea, both hair and supporting cells are developed by 14 days after fertilization (Ruben, 1967) . The ability for the mammalian perinatal cochlea to regenerate hair cells after this point suggests that the developing cochlea contains cells that are able to develop into hair cells. One group of researchers reported that the vestibular system, which does exhibit a low level of supporting cell proliferation after damage that continues into adulthood , contains pluripotent stem cells that maintain the additional ability to differentiate into noncochlear tissue such as muscle and nervous tissue (Li, Liu, & Heller, 2003;  Figure 7D ). In addition to this group, other groups have reported the ability to culture cochlear progenitor cells using the same methods utilized to culture neural stem cells (as floating spheres in serum-free media containing growth factors), which suggests that the perinatal cochlea contains a stem cell niche (Oshima et al., 2007; Oshima, Senn, & Heller, 2009; Senn, Oshima, Teo, Grimm, & Heller, 2007; Zhai et al., 2005; Zhang et al., 2007) .
Despite these data, it is not certain that the adult cochlea contains a population of ASCs. For example, the cochlear progenitor cells described above can be cultured only from embryonic and perinatal cochleas, not from mature ears. Additionally, in other ASC niches, such as the subventricular zone of the forebrain (Halliday & Cepko, 1992) or endothelial cells in the intestine (Halliday & Cepko, 1992; Leblond et al., 1967) , stem cells undergo a low rate of cell division and replace dead cells within the organ. There is no documentation that similar cellular proliferation and replacement rates occur in the adult mammalian cochlea.
However, data suggest that the cochlear supporting cells may function as hair cell progenitors during development, which differentiate into a more restricted number of cell types rather than bona fide multipotent stem cells capable of self-renewal. When isolated from the organ of Corti and cultured in vitro, cochlear supporting cells are capable of expressing hair cell markers such as myosin 7a, suggesting that they differentiate into hair cells (White et al., 2006) . However, once the supporting cells differentiate into hair cells, they do not repopulate themselves (Doetzlhofer et al., 2009 ). Therefore, supporting cells lack the ability to self-renew, which is a defining characteristic of a stem cell. Regardless of whether the cochlea contains a stem cell or progenitor niche, there must be some factors that inhibit the ability for stem/progenitor cells to differentiate into hair cells in the adult mammal.
Instead of stimulating endogenous stem-cell-toprogenitor-cell differentiation, other groups of investigators examined the ability of transplanted exogenous stem cells to replace damaged cells of the cochlea (see Figure 7C ). Although numerous studies showed that transplanted stem cells are able to survive within the cochlea for several weeks, the cell types into which they differentiate vary widely and are dependent upon the type of stem cell used for the transplants. For instance, embryonic stem cells that have been transplanted into the spiral ganglion of the cochlea were found to express neural markers (Hu, Andang, Ni, & Ulfendahl, 2005; Lang et al., 2008) and develop cellular processes similar to axons that extend toward the organ of Corti Martinez-Monedero, Corrales, Cuajungco, Heller, & Edge, 2006; Okano et al., 2005; Shi, Corrales, Liberman, & Edge, 2007) . These data suggest that embryonic stem cells have the ability to differentiate into neuronal cell types when transplanted into the spiral ganglion. Similarly, neural stem cells that have been transplanted into the scala tympani migrated to the spiral ganglion and then expressed characteristics of neurons and glial cells (Hakuba et al., 2005; Iguchi et al., 2003; Tateya et al., 2003) . In some instances, a small number of transplanted neural stem cells migrated to the scala media (Ito et al., 2001 ) and expressed organ of Corti markers, including hair cell markers (Parker et al., 2007; Wei et al., 2008 ). An additional study indicated that neural stem cells that migrated to the vestibular system expressed hair cell markers as well (Tateya et al., 2003) . These data suggest that neural stem cells express cochlear markers more readily than do embryonic stem cells. For example, the ability of transplanted cells to express hair cell markers in the cochlea-specifically, myosin 7a-has been demonstrated only through the use of neural stem cells (Parker et al., 2007; Tateya et al., 2003; Wei et al., 2008) . So far, it has been found that embryonic stem cells (Sakamoto et al., 2004) and the two stem cell populations present in the blood (mesenchymal and hematopoietic stem cells) are unable to express hair cell markers when transplanted into the cochlea (Tan, Lee, & Ruan, 2008) . One explanation for the ability of neural stem cells to more readily express cochlear markers than other stem cell types is that neural stem cells may be more closely related to cochlear tissue than other stem cell types. For instance, the cochlea and brain share similar signaling pathways during development. In fact, cochlear development is dependent on several signals secreted from the developing central nervous system (reviewed in Abello & Alsina, 2007; Schneider-Maunoury & Pujades, 2007; Streit, 2007; Whitfield & Hammond, 2007) . Likewise, neural stem cells and cochlear tissue express many of the same molecular markers such as GFAP, connexin 26, and myosin 7a (Parker et al., 2007) . Neural stem cells may more readily express these markers after transplantation than mesenchymal or embryonic stem cells because they have differentiated along more similar developmental pathways. Therefore, a shorter amount of reprogramming is required for an NSC to express markers of cochlear tissue.
Taken together, it can be said that the cochlea provides a permissive environment for stem cell incubation and that certain types of stem cells-especially neural and mesenchymal stem cells-maintain the ability to migrate throughout the damaged cochlea. The ability for the transplanted cell to migrate is important because a migrating cell presents an advantage in that it may be injected into the cochlea and then work its way to the site of lesion (reviewed in Parker & Cotanche, 2004) . Additionally, it appears that embryonic and neural stem cells maintain the potential to differentiate into neural cell types of the cochlea, which suggests that they may be useful in replacing lost spiral ganglion neurons. These data are encouraging for therapies aimed at replacing the cell types lost in neurodegenerative diseases involving the spiral ganglion such as auditory neuropathy and the spiral ganglion degeneration secondary to long-term Figure 7 . Stem cell replacement therapy in the cochlea. (see image on next page) Panel A: Pluripotent ESC are derived from the developing blastocyst and have the capacity to differentiate into any cell type. When these cells divide, the daughter cells maintain the capacity for self-renewal (see curved arrow) and the potential to develop into any cell type within the developing fetus. Adult stem cells (ASC), such as mesenchymal, neural, and intestinal stem cells, are multipotent cells found in the end-organs of adult tissue that maintain the ability for self-renewal and produce daughter cells that can differentiate into many of the cell types that comprise the organ in which they reside. By contrast, progenitor cells exhibit a more limited potential and differentiate into a restricted number of cell types. Panel B: The goals of stem cell replacement therapy are to use ESC, ASC, or cochlear progenitor cells to replace dead or damaged cell types that result in hearing loss. Panel C: Initial experimenters aiming to achieve this goal injected various types of stem cells into the deafened cochlea and later examined the differentiated fates of the transplanted stem cells. As discussed in the text, most stem cell types were able to survive transplantation and engraft into the cochlea, but the terminal cell type and their degree of differentiation depended on the specific type of injected stem cell. (Berlin, Morlet, & Hood, 2003; Lang et al., 2008; Shi et al., 2007) .
It should be noted, however, that stem cell transplantation into the cochlea exhibits a limited potential for widespread differentiation into organ of Corti cell types. It is important to note that even though the aforementioned studies show that transplanted stem cells adopt some molecular markers of cochlear cell types, the expression of a few molecular markers does not necessarily indicate that these cells fully develop into mature neural or sensory tissue. More troubling than the inability to completely differentiate into cochlear cell types is the fact that some stem cell types have the propensity to develop tumors when transplanted into the cochlea (Lang et al., 2008) . Finally, the fact that transplanted ESC extend processes toward hair cells is encouraging, but it is not conclusive evidence of their utility in treating SNHL. For example, it is yet to be determined whether these processes form functional synaptic contacts with hair cells or extend processes centrally into the cochlear nucleus of the brainstem, as do the endogenous spiral ganglion neurons. Therefore, these experiments represent a promising initial wave of investigations regarding the use of stem cells in cell replacement therapy for hearing loss, but much more work is required before this technology is clinically feasible.
This limited potential may be due to a lack of control over the stem cell differentiation after transplantation into the cochlea. Once injected, stem cells have been left to differentiate by their own devices, and there has been little attempt to drive stem cell differentiation along a cochlear pathway (Parker & Cotanche, 2004) . Rather than inject naive stem cells into the adult cochlea, it may be more beneficial to lead the exogenous stem cells along a hair cell pathway by sequentially exposing them to signals that are present in the developing cochlea (Oshima et al., 2010) . This can be accomplished by exposing stem cells to these signals in vitro prior to transplantation, genetically engineering the stem cells to sequentially express these signals after transplantation, or a combination of both techniques. Current research in both developmental and stem cell biology is focusing on identifying the complete list of morphogens, growth factors, and signaling ligands involved in hair cell development. Once the essential signaling pathways and gene expression patterns are determined, they will be used to drive stem-cell-to-hair-cell differentiation. Alternatively, inner ear stem cells may be used in cell replacement therapy. Inner ear stem cells possess an advantage over other stem cell types because they are derived from the cochlear or vestibular tissue and have been exposed to the aforementioned signals during normal development. Currently, there are several groups actively pursuing these avenues of research.
Gene Therapy for the Treatment of SNHL
Gene therapy involves the up-regulation or downregulation of specific genes in order to treat human disease (reviewed in B. R. Snyder, Boulis, & Federici, 2010; D. R. Wilson, 2002; Young, Searle, Onion, & Mautner, 2006) . One technicality with gene therapy, in general, concerns the method of injecting the gene-which consists of a segment of DNA-into the target cell. Genes can be inserted into cells by the use of electric pulses (Neumann, Schaefer-Ridder, Wang, & Hofschneider, 1982; Zheng & Gao, 2000) , encasement in lipid-like spheres (Fassati, Takahara, Walsh, & Dickson, 1994) , or packaging into viruses (Aposhian, Barr, & Keck, 1977; Han et al., 1999; Zheng, Lewis, & Gao, 1998 ; see Figure 8 ). For example, viruses are efficient at infecting a host cell with their own DNA and have been used successfully as vehicles for gene delivery in many different systems. In a viral-mediated gene delivery system, most of the viral DNA is deleted and replaced with a gene-of-interest before it is repackaged back into the virus. In this system, any cell that comes into contact with the virus may be infected with the gene-of-interest.
Although research into gene therapy had begun in earnest during the early 1970s (Aposhian, 1970; Osterman, Waddell, & Aposhian, 1970) , its application to SNHL is relatively recent, having started about a decade ago with the discovery of the pro-hair cell gene atoh1 (Bermingham et al., 1999 ; see Figure 9 ). Further studies indicated that expressing atoh1 in the mammalian cochlea is sufficient (i.e., no other signals are required) for hair cell genesis in the developing cochlea (Bermingham et al., 1999; Zheng & Gao, 2000) and adult cochlea (Izumikawa et al., 2005; Kawamoto, Ishimoto, Minoda, Brough, & Raphael, 2003) . Misexpression studies, in which genes are expressed in atypical patterns (such as overexpression) or in atypical cell types, have shown that cells which up-regulate atoh1 within the prenatal (Brigande, Gubbels, Woessner, Jungwirth, & Bresee, 2009; Gubbels, Woessner, Mitchell, Ricci, & Brigande, 2008) and perinatal organ of Corti (Zhai et al., 2005; Zheng & Gao, 2000) will also up-regulate hair cell markers such as myosin 7a and adopt morphological characteristics of hair cells such as cilia (see Figures 9B and 9C) . Taken together, these data indicated that the expression of atoh1 in cells within the prenatal and perinatal mammalian cochlea is sufficient for hair cell genesis and have led to the use of this gene as an experimental therapy for the treatment of SNHL in mammalian animal models.
One group of researchers engineered a virus to express atoh1 and then injected this virus into the cochleas of drug-deafened adult guinea pigs (Kawamoto et al., 2003 ; see middle panel of Figure 8 ). The data showed Figure 8 . Gene delivery in hearing research. Panel 1: Viral-mediated gene delivery utilizes virus particles to deliver a gene-of-interest into a cell. A: A virus (blue) attaches to a cell (see Subpanel B). Once attached, the DNA of the virus (see black vertical line) will be inserted into the cytoplasm of the host cell (see Subpanels 1C and 1D), where the viral DNA will incorporate into the DNA of the host cell (red; see Subpanel 1E). Viral DNA consists of self-replicating genes and will cause the host cell to manufacture more viral particles (see Subpanel 1F). Subpanel 1G: Eventually, the host cell will release viral particles back into the environment. Subpanel 1H: In a viral-mediated gene delivery system, the viral DNA that codes for self-replication is replaced with a gene-of-interest, such as atoh1. Cells that are infected with the engineered virus will express the atoh1. Raphael [2005] , "Auditory hair cell replacement and hearing improvement by atoh1 gene therapy in deaf mammals," Nature Medicine, 11, pp. 271-276). P = pillar cells. Panel 3: Genes can also be delivered into the inner ear using pulse trains of electric charge (known as electroporation). Gubbels et al. (2008) injected atoh1 DNA into the developing otocysts of E11.5 mice in utero, electroporated the embryos, allowed them to mature, and then analyzed the cochleas at various time points for hair cell markers. These results indicated that the overexpression of atoh1 during embryogenesis resulted in extra rows of functional hair cells into adulthood. Arrows at the far right point to hair cells that exhibit abnormal stereocilia. that the infected animals exhibited more hair cells than did the sham-infected controls. The structure of some of the regenerated hair cells was surprising because the cells had maintained the general morphology of a supporting cell-with a nucleus close to the basilar membrane-but had grown cilia on their apical surface, similar to a hair cell (see Figure 9D ). This result suggests that atoh1 may allow supporting cells to directly transdifferentiate into hair cells as observed in chickens. Furthermore, the infected animals demonstrated an improvement in auditory brainstem response thresholds relative to sham-infected controls, indicating that Figure 9 . Expression of the atoh1 gene in the organ of Corti is sufficient for hair cell genesis. Panel A: In situ hybridization (ISH) shows that hair cells express RNA for atoh1 gene (black) by E17. Arrow at bottom right indicates Deiters' cell layer. Panels B and C: Organs of Corti (OC) that were isolated from perinatal rats then electroporated with the atoh1 gene tagged with a GFP marker (green) expressed the hair cell marker myosin 7a (red) when assayed by immunohistochemestry, indicating that these cells expressed hair cell-specific markers. Most of the regenerated hair cells were seen in Kölliker's organ (a.k.a. the greater epithelial ridge [GER] ). The image depicted in Panel C is an overlay of the images depicted in Panels A and B and was adapted with permission from Macmillan Publishers Ltd, © 2000 (J. L. Zheng & W. Q. Gao [2000] , "Overexpression of math1 induces robust production of extra hair cells in postnatal rat inner ears," Nature Neuroscience, 3, pp. 580-586). Panel D: Adult guinea pigs were deafened, and then their cochleas were infected with a virus that had been engineered to deliver atoh1. Numerous regenerated hair cells appeared in the infected cochleas. In some cases, the regenerated hair cells maintained the morphology of ciliated supporting cells (nucleus close to basilar membrane with a cellular process that reached the reticular lamina). White atoh1-infected animals were able to recover some hearing function that would have been lost due to the ototoxic insult (Izumikawa et al., 2005) . It is interesting to note that similar experiments showed that forced expression of atoh1 failed to produce hair cells when infected into cochleas lacking any supporting cells (Izumikawa, Batts, Miyazawa, Swiderski, & Raphael, 2008) , which suggests that the presence of supporting cells is a prerequisite for atoh1-induced hair cell regeneration in mammals. This datum is also noteworthy because it is the first time that hair cell regeneration has been documented in an adult mammal and suggests that the use of atoh1 as gene therapy may be useful in treating SNHL in adults.
However, it is important to note that this research is in its infancy and will not be ready for clinical use for several years. A number of obstacles remain to be surmounted before gene therapy can be used effectively and safely in the clinic. Foremost is that these results have yet to be verified by an independent laboratory and, therefore, remain somewhat controversial. Perhaps the greatest obstacle for gene therapy involves the cell specificity of gene-delivery systems. Most gene-delivery vectors, such as viruses, will infect cells randomly. Therefore, the gene-of-interest will be expressed in random cell types. In the case of viral-mediated delivery of atoh1, ectopic hair cells were produced in unexpected regions of the organ of Corti, such as the spiral limbus, inner sulcus, and Hensen's cells (see Figure 9E ). Although this datum provides important information regarding the identities of the specific supporting cell types capable of hair cell differentiation, the formation of ectopic hair cells is problematic from a clinical standpoint. Additionally, the viral vectors themselves may present a significant health risk (Connolly, 2002) . Furthermore, safe injection of virus particles into the scala media requires a complicated surgical procedure that has not yet been optimized. Other common gene-delivery systems such as lipophilic vectors and electroporation result in similar roadblocks. Nonetheless, current research being conducted in several laboratories is addressing these shortcomings. For example, multiple laboratories are developing new generations of gene-delivery systems aimed to provide more safety to a clinical population (Pathak, Patnaik, & Gupta, 2009; B. R. Snyder et al., 2010) . Additionally, several laboratories are developing cell-specific delivery systems for genes such as atoh1 (Parker, Jiang, Adams, & Edge, 2011) . This research is continuing at a rapid rate and is being conducted by teams of talented researchers.
Conclusion
Even with the acknowledgement of their current limitations, biological approaches may represent the future for the treatment of SNHL. Currently, hearing aids remain the treatment of choice for mild-to-severe SNHL, and cochlear implants remain the gold standard for the treatment of profound deafness. However, it is unclear whether current amplification and implant technology has plateaued. Given a need for improvement in the cochlear implant performance, it may be that biological approaches will eventually result in more effective treatments for SNHL than electronic approaches. Alternatively, it may be that a biological approach combined with a cochlear implant system will improve its efficacy.
Currently, mammalian hair cell regeneration using stem cell and gene therapy for the treatment of SNHL is years-if not decades-away from being clinically feasible. However, significant progress has been made in this area since the discovery of hair cell regeneration 30 years ago. For instance, it is possible to regenerate hair cells in the mammalian cochlea after their critical period of development using gene therapy. Furthermore, it may possible to replace damaged auditory neurons using stem cells. However, there are limitations to each of these approaches, and the efficacy of these treatments needs to be methodically investigated. It may be that a combination of approaches will be the most effective means of accomplishing the goal of cochlear repair. Hearing aids and cochlear implants remain the standard treatment for SNHL and deafness; however, if the goals of the biological approaches are met, to structurally repair the damaged cochlea, then these therapies may represent the future treatments for SNHL.
